Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Austria

Marie Skłodowska-Curie Action · Running

spaXio Spatial Crosstalk in Immuno-Oncology

Coordinator
Paris-Lodron-Universitat Salzburg, Austria
Runs
1 October 2025 to 30 September 2030
Status
Running
EU funding
€4.4m
Total cost
—
Partners
19 organisations in 6 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101226364

What the project is doing

In the project's own words, from its summary on CORDIS.

Metastasis, the leading cause of cancer-related deaths, arises from the spread of cancer cells to distant organs, where they compromise normal organ function. Cellular interactions, paracrine factors, and the metabolic environment promote the formation of metastatic niches that facilitate tumour cell survival and proliferation. While single-cell data have improved our understanding of tumours and their heterogeneity, our knowledge of metastatic niches is still very incomplete.

In particular, the lack of spatial context makes it difficult to address critical knowledge gaps in metastatic niche biology which limits our progress in the development of targeted therapeutic interventions. The doctoral network spaXio aims to tackle this challenge by training doctoral candidates (DCs) in cutting-edge techniques, including spatially resolved multi-omics, advanced tumoroid modelling, and computational approaches, including bioinformatics and AI-based prediction models.

DCs will conduct systemic analyses of metastatic niches across diverse organ systems and tumour types to improve our understanding of metastatic niche formation and uncover novel therapeutic targets. SpaXio provides comprehensive, multidisciplinary training that combines hands-on laboratory experience, computational data integration, and (industry) secondments. Regular cross-disciplinary workshops and seminars boost innovation and collaboration, while transferable skills training encompasses communication, ethical research, open science, entrepreneurship, and sustainability.

By partnering with a network of leading European and international academic, clinical, and industrial experts, spaXio ensures that DCs are exposed to diverse research environments and approaches. This fosters their ability to think across borders, advance technologies and integrate multiple large datasets into a complete systemic picture, preparing them to be leaders in cancer research and shape the rapidly evolving field of spatial biology.

Topics

Who is involved

OrganisationCityCountryRole
Paris-Lodron-Universitat SalzburgSalzburgAustriaCoordinator
Molecular Devices (Austria) GmbHUrstein bei HalleinAustriaAssociatedpartner
Sumo Technologies GmbHWienAustriaAssociatedpartner
Centre Hospitalier Universitaire VaudoisLausanneSwitzerlandAssociatedpartner
Universite De LausanneLausanneSwitzerlandAssociatedpartner
Eberhard Karls Universitaet TuebingenTuebingenGermanyParticipant
Miltenyi Biotec BV & Co KgBergisch GladbachGermanyAssociatedpartner
Technische Universitaet MuenchenMuenchenGermanyParticipant
Waters GmbHEschbornGermanyAssociatedpartner
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Universidad Autonoma De MadridMadridSpainAssociatedpartner
DeeplifeVernonFranceParticipant
Institut National De La Sante Et De La Recherche MedicaleParisFranceParticipant
OkomeraParisFranceAssociatedpartner
PhasicsSaint-AubinFranceAssociatedpartner
Protisvalor Mediterranee SASMarseilleFranceAssociatedpartner
Universite D'aix MarseilleMarseilleFranceParticipant
10x Genomics, Inc.PleasantonUnited StatesAssociatedpartner
Akoya Biosciences, Inc.MarlboroughUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI